What Will the Next Wave of Life Sciences Innovation Bring?

What Will the Next Wave of Life Sciences Innovation Bring?

In this edition of Foresight, we examine cutting-edge developments like 3D-printed surgical models and AI-powered diagnostics that are transforming healthcare delivery. As the pace of change accelerates, these innovations hold the key to unlocking new efficiencies, reducing costs, and improving patient care. Explore the future of healthcare and how leading organizations are capitalizing on these trends.


Overcoming Challenges in 3D-Printed Surgery: Cost, Accuracy, and Adoption

The global market for 3D-printed anatomical models is set to reach $1.9 billion by 2030, growing at a CAGR of 15%. These models enhance pre-surgical planning, reducing operative time, complexities, and procedure costs. Advances in techniques like stereolithography deliver high-resolution models, closely replicating real organ properties. However, broader adoption requires overcoming reimbursement challenges. FutureBridge emphasizes that collaboration to standardize billing codes and demonstrate cost-effectiveness will be crucial for expanding the clinical use of 3D models...explore the full article here


Harnessing AI for Respiratory Care: Driving Accuracy, Efficiency, and Patient Outcomes

With the global AI healthcare market projected to grow from USD 19.54 billion in 2023 to USD 490.96 billion by 2032, AI-driven innovations are transforming patient care. AI solutions like Lucem Health's 'Reveal', which improves early lung cancer detection rates by 60%, highlights the growing importance of AI in respiratory care. FutureBridge believes the rise in AI-driven early lung screening initiatives will enhance the early detection and treatment of lung abnormalities, potentially saving numerous lives and reducing healthcare costs...access this report


Reshaping Oncology with TPDs: Unlocking New Therapeutic Pathways

Building on the transformative potential of Targeted Protein Degraders (TPDs), this cutting-edge approach is unlocking therapies for diseases once deemed untreatable, particularly by addressing "undruggable" proteins. With 80% of TPDs still in early development, they are rapidly reshaping the oncology space, notably through selective estrogen receptor degraders (SERDs) targeting breast cancer. Backed by promising efficacy from PROTACs and market projections of USD 300 million by 2030, TPDs will revolutionize pharmaceutical pipelines and drive the future of precision medicine...discover more


AI in MedTech: Redefining Diagnostics and Patient Care

AI is powering sustainable innovation in MedTech by optimizing resource management and reducing environmental impact. Companies like CJ Biomaterials are using AI-powered platforms like PolymRize? to develop eco-friendly materials, such as PHACT, a 100% biodegradable polymer. AI also plays a key role in monitoring carbon footprints, driving a circular economy, and improving energy efficiency—enabling up to 30% savings in hospital energy consumption. FutureBridge highlights that embracing AI solutions like these will be crucial for manufacturers to align their growth with sustainability goals and enhance operational efficiency...explore the complete infographic here


DOWNLOAD REPORT


What’s covered in this executive report:

- Explore recent approvals and their significance.

- Analysis into near-approval and emerging cell therapies.

- Innovations reshaping chimeric antigen receptor technology.

- ACT by indication, target, and mechanism.

- Detailed profiles of transformative technologies.

- Key trends and drivers shaping the cell therapy landscape.

- Perspectives from our Life Sciences team.

Leverage our proprietary intelligence to stay ahead of clinical breakthroughs, R&D milestones, and market shifts driving the future of cell therapies. Download executive report


UPCOMING DISCUSSIONS


Join the conversation with industry experts and be a part of bold trends in innovative technologies.

1.How is the Li-battery value chain evolving in the US and EU?

Date: September 26, 2024

Time: 10.30 AM CET | 4.30 PM CET | 2.30 PM EST

Register here

2. Reality Check on Self Driving Cars

Date: October 4, 2024

Time: 10.30 AM CET | 4.30 PM CET | 2.30 PM EST

Register for this webinar today and unlock your exclusive 14 days of Complimentary Access?to our premier FutureBridge Mobility Platform.


3. From Foundry to Future: How Giga Casting is Redefining Automotive Production

Date: October 10, 2024

Time: 10.30 AM CET | 4.30 PM CET | 2.30 PM EST

Register for this webinar today and unlock your exclusive 14 days of Complimentary Access?to our premier FutureBridge Mobility Platform.

4. Small Reactors Big Solutions: Can SMRs Address Energy Challenges?

Date: October 10, 2024

Time: 10.30 AM CET | 4.30 PM CET | 2.30 PM EST

Register for this webinar today and unlock your exclusive 14 days of Complimentary Access?to our premier FutureBridge Energy Intelligence Platform.



About FutureBridge

FutureBridge is a techno-commercial consulting and advisory company.?We track and advise on the future of industries from a 1-to-25-year perspective to?keep you ahead of the technology curve, propel your growth, identify new opportunities, markets and business models, answer your unknowns, and facilitate best-fit solutions and partnerships using our platforms, programs, and access to global ecosystems and players.

Contact Us |?Follow us on LinkedIn, X and YouTube


要查看或添加评论,请登录

社区洞察

其他会员也浏览了